After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine has laid out plans to raise about $292 million through a listing on the ...

Fashion designer Pam Hogg, known for her punk rock, non-conformist creations who dressed stars such as Rihanna and Lady Gaga, has died, her family announced on Wednesday. Hogg was an iconic figure of ...

The fashion designer found dead on a boat at a Long Island yacht club had “only trace amounts” of cocaine in her system, her family’s autopsy reportedly found, appearing to clash with a statement by ...

The Little Rock Police Department arrested a man early Monday morning on gun and drug charges, according to an arrest report. Jimmy Lee Barrow, 43, was arrested at 1:20 a.m. following a traffic stop ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and inflammation, potentially offering a powerful new way to protect the heart ...

B King became the focus of a murder probe after he and DJ Regio Clown were slain in a turf war over Mexico’s lucrative pink “tusi” drug. B King became the center of a deadly criminal probe after his ...

If your fall wardrobe is craving a refresh (and your wallet is begging for mercy), then right this way - Anthropologie just dropped a wave of new sale dresses, many coming in at under $150. Yes, you ...

A Rock Hill woman whose illegal drug use while pregnant ended with the baby’s stillbirth has been sentenced to 12 years in prison. Shannandoah Tiffany Harris, 27, used fentanyl and methamphetamine ...

After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its remaining strategic commitment by reupping a pact with AI drug designer Nabla Bio.

Living by the creed of "sex, drugs and rock 'n' roll" can be a lot of fun. But as anyone who has tried that approach likely knows, it can also get out of hand quite quickly. Drugs in anyone's world, ...

Sept 23 (Reuters) - Scholar Rock (SRRK.O), opens new tab said on Tuesday the U.S. health regulator has declined to approve its drug for a rare neuromuscular disease citing issues at a third-party ...

Scholar Rock’s bid to become the first company to win FDA approval for a muscle-targeted treatment for spinal muscular atrophy (SMA) has been tripped up by a manufacturing issue. The FDA sent a ...